ACHIEVEMENT OF MOST OF 2019 TARGETS ONE YEAR IN ADVANCE AND SUCCESSFUL INTEGRATION OF HIGHLY ACCRETIVE ACQUISITIONS. 2019 COST TARGET ANNOUNCED

Amsterdam, Brussels, Dublin, Lisbon, London and Paris – 14 February 2019 – Euronext, the leading pan-European exchange in the Eurozone with 1,300 listed issuers, today announces its results for the full year 2018.

Strong increase of Euronext performance through 2018

• Double digit growth in full year 2018 revenue to €615.0 million (+15.5%^[1]), driven by:
  • Improved Group revenue diversification initiatives with contributions from Euronext Dublin of €24.6 million for 9 months of consolidation, FastMatch of €21.7 million and selected growth initiatives of €17.6 million
  • Listing revenue at €106.5 million (+26.4%) driven by the consolidation of Euronext Dublin and good performance of Corporate Services (€16.6 million)
  • Strong cash trading revenue of €210.9 million (+10.9%), through enhanced market share to 66.1% in 2018 (+1.7pts), effective yield management at 0.51bps (+4.9%), and improved volumes (Cash ADV at €8.1bn, +5.7%)
  • Strong performance of Advanced Data Services[2] with revenue at €118.3 million (+13.0%)
  • Non-volume related revenue accounted for 44% of total revenue in 2018, and covered 104% of operating expenses excluding D&A
• Double digit growth in full year 2018 EBITDA to €354.3 million (+19.0%), with EBITDA margin at 57.6% (+1.7pts) in a year of consolidation of recent acquisitions and delivery of major steps of Optiq® trading platform:
  • Decrease of core business costs (-4.3%) thanks to costs discipline and with significant savings generated by the successful delivery of Optiq® for cash markets
  • Group operating costs (excluding D&A) up (+11.2%) mainly impacted by the consolidation of Euronext Dublin and FastMatch, and related one-off costs
• Double digit growth in full year 2018 adjusted EPS at €3.44[3] (+11.2%). Decrease in EPS (basic) to €3.10 (-10.5%), because of negative comparison base in 2017 with one-off capital gain from LCH SA share swap and non-recurring tax release:
  • Net income, reported, share of the Group, at €216.0 million driven by strong operating performance, while impacted by €21.5 million of exceptional items and by €5.3 million of net financing expenses
• In accordance with Euronext dividend policy, a pay-out ratio of 50% of reported net income representing a dividend for 2018 of €108 million (€1.54 per share) will be proposed to the AGM[4] on 16 May 2019. As a reminder, dividend for 2017 was positively impacted by significant one-off such as capital gain from LCH SA share swap and non-recurring tax release

Achievement of most of 2019 targets of Agility for Growth strategic plan one year in advance, confirming Q3 2018 momentum

• “Deliver value to shareholders”:
  • 2018 core business and selected growth initiatives (excluding clearing) EBITDA margin at 61.6%, reaching one year in advance the 61-63% 2019 EBITDA margin target
  • ~€340 million of capital deployed in revenue diversification and expansion of Euronext decentralised model
  • ~€100 million of capital deployed in bolt-on deals, in the initial €100-150 million envelope
  • Euronext rated A (outlook stable) by S&P, in line with expected investment grade profile
•  “Enhance agility”:
  • 2019 cost reduction target achieved one year in advance with €23.8 million of cumulated core business gross savings achieved since Q2 2016 (vs. €22 million targeted) thanks to continued cost discipline, with less than half of expected restructuring costs incurred (€14.6 million vs. €33 million targeted)
  • Optiq® trading platform delivered in 2017 for Market Data, 2018 for Cash markets, February 2019 for Euronext Dublin and planned by the end of 2019 for Derivatives markets
• “Strengthen resilience of the core business”:
  • Continued core business revenue growth: +2.0% CAGR_2015-2018 vs. 2.0% CAGR_2015-2019 targeted
  • Increased market share on cash trading to 65% on average since 2017 (vs. >60% targeted) and >50% on French equity options (vs >50% targeted), and sustained yield on cash trading
• “Grow in selected segments”: €17.6 million incremental revenue in 2018 vs. €55 million targeted in 2019. Corporate Services recorded strong performance and the Tech SMEs initiative achieved good traction. ETF MTF is expected to be live in 2019. Other initiatives are not expected to provide further revenue in 2019. Euronext will continue the development of innovative projects and organic initiatives
• “Create optionality in clearing” with investment in EuroCCP in 2016 and the renewed 10-year agreement with LCH SA along with a 11.1% equity stake and a strong pre-emption right in 2017. Preferred user choice model for equity clearing is now live

Continued business diversification through highly accretive acquisitions

• Euronext Dublin contributed €24.6 million to Group revenue, for 9 months of consolidation, and ran a successful integration process with merged cross-border teams and administration systems. €2.7 million synergies were extracted in 2018
• FastMatch reported a strong performance contributing €21.7 million revenue in 2018 with a renewed management

Contemplated acquisitions of Oslo Børs VPS

On 14 January 2019, Euronext launched an all-cash tender offer to acquire all issued and outstanding shares of Oslo Børs VPS Holding ASA (“Oslo Børs VPS”). The original offer price of NOK145 per share, ie NOK6.24 billion (€625 million^[5]) for all outstanding shares of Oslo Børs VPS, has been amended to NOK158 per share, ie. NOK6.79 billion (€695 million[6]) on 11 February 2019 and the acceptance period will expire on 11 March 2019 and can be extended as appropriate. The offer remains subject to conditions presented in the offer document[7] and in the press release published on 11 February 2019³. This transaction would follow Euronext’s recent acquisition of Euronext Dublin (formerly the Irish Stock Exchange) and would represent another key milestone in the delivery of the group’s vision to build a consistent pan-European marketplace offering best-in-class capital markets services.

Cost guidance for 2019

In 2018, Euronext has extended its scope of activity both organically and through acquisitions. Furthermore, most of the core business 2019 targets of the Agility for Growth plan have been achieved one year in advance. To simplify and improve the tracking of its performance, Euronext will now report only group performance (including selected growth initiatives and new perimeter). New mid-term targets will be presented in H2 2019 as a part of the new strategic plan. In 2019, Euronext expects to limit the growth rate of its operating costs to a low single digit[8], despite the consolidation of Euronext Dublin for the full year of 2019[9].

Stéphane Boujnah, Chief Executive Officer and Chairman of the Managing Board of Euronext, said:

“Euronext delivered a strong financial performance in 2018 with double digit growth in revenue, EBITDA and adjusted EPS thanks to strengthened core business and market share on cash trading at 66%. Combined with efforts on cost, Euronext was able to reach most of its 2019 targets one year in advance, confirming the Q3 2018 momentum, with a core business and selected growth initiatives EBITDA margin reaching 61.6%. In 2018, Euronext successfully welcomed Euronext Dublin teams within the Group and achieved the migration of Irish markets to Optiq trading platform early February 2019, seven months after its transition for the Group cash markets. Euronext is pursuing its European strategy with the project to acquire Oslo Børs VPS, to reach another milestone in its value creation strategy and to fulfill its mission to finance the real economy in Europe. The Group is committed to deploy its capital and to analyze further acquisitions to expand its decentralized model in Europe and diversify its revenue profile.

Euronext Group has transformed itself in the past three years, with a top line growing by around €100m thanks to combined organic and external growth. In order to fully reflect the new Group, and given that most of the 2019 announced core business targets were met one year in advance, Euronext provides a costs guidance for 2019, prior to the release of its new strategic plan later this year, that will better help our stakeholders to assess its performance. For 2019, Euronext expects a low-single digit growth of Group operating expenses (excluding D&A) compared to 2018, thanks to its continued strong cost discipline.”

Capital raised through IPO will enable the execution of Sequana Medical’s strategy

Brussels, 11 February 2019 – Belgian-based medtech company Sequana Medical NV (ticker symbol: SEQUA) today began trading on Euronext Brussels (Compartment C) with an initial market capitalisation of approximately €107.2 million. This transaction demonstrates the attractiveness of Euronext as the leading stock exchange for European biotech and medtech companies. With this operation, Sequana Medical joins a large franchise of 89 life science companies (52 biotech and 37 medtech companies) currently listed on Euronext’s markets, representing a total market capitalisation of €22 billion per 31 January 2019.

Sequana Medical NV is a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical's first product is the alfapump®, a fully implantable, programmable, wirelessly-charged, battery-powered system. It has been approved in Europe for the treatment of liver refractory ascites and malignant ascites and has shown a strong performance in multiple clinical studies and over 650 implants. The alfapump® has recently been granted breakthrough device designation by the US FDA. The Company is also developing alfapump® DSR (Direct Sodium Removal), a novel and proprietary approach to the treatment of volume overload in heart failure for which a first-in-human study is ongoing.

Founded in Switzerland in 2006, Sequana has established its new corporate headquarters in Ghent, Belgium, in order to benefit from Belgium’s attractive healthcare ecosystem and ultimately to list on Euronext Brussels, one of the most dynamic stock exchanges in Europe for life sciences IPOs.

With an initial reference price set at €8.5 per share, Sequana Medical’s initial market capitalization stands at €107.2 million.

Ian Crosbie, Chief Executive Officer of Sequana Medical, said: "We are very pleased with the successful closing of our IPO on Euronext Brussels, which is renowned for being very supportive of high-quality listings in the healthcare space. The funds raised will support our commercial and clinical development with the goal to make the alfapump® and alfapump® DSR available to a broader patient group and address important unmet medical needs. We would like to thank all of our existing shareholders and our new investors for their support in making this transaction a success and we are looking forward to entering this exciting new phase for our Company."

To mark Sequana Medical’s first trading day, Ian Crosbie, Chief Executive Officer of Sequana Medical, rang the bell to open the markets in Brussels today.

_{About Sequana Medical
Sequana Medical is a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders.}

_{Sequana Medical's alfapump® is a fully implantable, programmable, wirelessly-charged, battery-powered system that is CE-marked for the management of i) refractory ascites (chronic fluid build-up in the abdomen) due to liver cirrhosis and ii) malignant ascites (with a life expectancy of six months or less). The number of patients with liver refractory ascites is forecast to increase dramatically due to the growing prevalence of NASH (Non-alcoholic Steatohepatitis).}

_{Over 650 alfapump® systems have been implanted and since April 2018, the alfapump® has been included in the EASL (European Association for the Study of the Liver) clinical practice guidelines for decompensated cirrhosis. In January 2019, the FDA has granted Breakthrough Device designation for the alfapump® for the treatment of liver recurrent or refractory ascites. The alfapump® MOSAIC North American IDE feasibility study in patients with liver refractory or recurrent ascites has been completed and results were presented at the AASLD (American Association for the Study of Liver Diseases) annual meetings in October 2017 and November 2018. The alfapump® has not yet received regulatory approval in the U.S.}

_{The alfapump® is one of the first safe and effective, long-term alternatives to large-volume paracentesis which is a lengthy, invasive and painful procedure, only providing short-term symptomatic relief, requiring hospital visits and placing a significant burden on the healthcare system and patient quality of life. By automatically and continuously moving ascites to the bladder, where the body eliminates it naturally through urination, the alfapump® prevents fluid build-up and its possible complications, improving patient quality of life and nutrition, and potentially reducing hospital visits and healthcare costs. The alfapump® DirectLink technology allows clinicians to receive pump performance information and more effectively manage patients treated by the alfapump®.}

_{Sequana Medical is developing the alfapump® DSR, built upon the proven alfapump® platform, to deliver a convenient and fully implanted system for Direct Sodium Removal ("DSR") therapy, a novel and proprietary approach for the management of volume overload in heart failure. Data from animal studies presented at EuroPCR 2018 and HFSA 2018 indicate that DSR therapy is effective and safe. A first in human study for DSR therapy is ongoing. Treatment of volume overload in diuretic-resistant heart failure patients is a major clinical challenge. There are an estimated one million hospitalisations due to heart failure in the U.S. each year, of which 90% are due to symptoms of volume overload. The estimated cost of heart failure-related hospitalisations in the U.S. is $13 billion a year.}

_{Sequana Medical is headquartered in Ghent, Belgium and investors include NeoMed Management, LSP (Life Science Partners), VI Partners, BioMedPartners, Capricorn Venture Partners, Entrepreneur's Fund, Salus Partners, Newton Biocapital, PMV and SFPI-FPIM. For further information, please visit www.sequanamedical.com.}

Amsterdam, Brussels, Dublin, Lisbon, London and Paris – 6 February 2019 – Euronext, the leading pan-European exchange in the Eurozone, today announced trading volumes for January 2019.

Cash trading

In January 2019, the average daily transaction value on the Euronext cash order book stood at €6,708.1 million, down -16.0% compared to January 2018 and down -15.1% from the previous month.

The average daily transaction value on the ETF order book was €205 million, down -28.3% compared to January 2018 and down -19.4% from the previous month. At the end of January 2019, 1,168 ETFs were listed on Euronext compared to 1,150 at the end of Deccember 2018.

Derivatives trading

In January 2019, the overall average daily volume on derivatives reached 523,542 contracts, down -6.7% compared to January 2018 and down -19.6% compared to the previous month. In detail:

• the average daily volume on equity index derivatives reached 214,202 contracts, up +7.3% compared to January 2018 and down -25.0% from the previous month,
• the average daily volume on individual equity derivatives reached 268,304 contracts, down -14.4% compared to January 2018 and down -18.2% from the previous month,
• the average daily volume on commodity derivatives reached 41,036 contracts, down -14.5% compared to January 2018 and up +8.2% from the previous month.

At the end of January 2019, the open interest was flat at 16,720,087 contracts (-0.6% compared to the end of January 2018).

FX spot trading 

In January 2019, the average daily volume on the spot foreign exchange market of FastMatch, operating as a Euronext company since August 2017, stood at $20,050 million, down -3.5% compared to January 2018 and up +4.9% from the previous month.

Listings

As part of its SME Tech initiative, Euronext has welcome Italy Innovazioni, a Rome-based start-up focused on smart devices that capitalised €11 million through its listing on Euronext Access. In addition, €3.2 billion were raised in follow-on equity, including €430m from Takeaway to finance its acquisition of DeliveryHero Germany.

In January 2019, €96 billion were raised on Euronext in bonds. These included two green bonds from Engie and RFF worth a combined €1.5 billion, taking the total green bonds issuance on Euronext to €55 billion.

Amsterdam, Brussels, Dublin, Lisbon, London and Paris – 4 February 2019 – Euronext acknowledges the decision of the Board of Directors of Oslo Børs VPS Holding ASA (“Oslo Børs VPS”) not to recommend Euronext’s offer[1], even though Euronext’s offer is supported by the majority of Oslo Børs VPS shareholders.

Euronext launched on 14 January 2019 an all-cash tender offer to acquire all issued and outstanding shares of Oslo Børs VPS for NOK 6.24 billion, and had already secured support for the offer from the majority of Oslo Børs VPS shareholders representing 50.5% of the total number of outstanding shares through irrevocable binding pre-commitments to tender shares in the context of the offer, and share purchases. Euronext’s offer is subject to a 50.01% minimum acceptance condition, which is already met. Euronext, which is already regulated in Belgium, France, Ireland, the Netherlands, Portugal and the United Kingdom, is currently awaiting the Ministry of Finance's decision of its ownership application (based on advice from the Norwegian Financial Supervisory Authority (Finanstilsynet)) in order to complete the acquisition of all shares tendered in favour of its offer.

Euronext is determined to acquire Oslo Børs VPS and remains committed to a constructive and continuous dialogue with Oslo Børs VPS shareholders, Board and management as well as the wider Norwegian ecosystem. Euronext’s Reference Shareholders have also confirmed their joint support to Euronext for this transaction. Euronext will assess available options to adjust its offer and will communicate when appropriate.

Euronext is strongly convinced of the benefits that its combination with Oslo Børs VPS would bring to all Norwegian stakeholders. It has a strong track record of pan-European and decentralised independent market infrastructure management. Euronext’s model, capitalising on local strengths, identity and vibrant markets, fuels its ambition to finance the real economy, especially SMEs, by providing them with access to the largest liquidity pool in Europe. Euronext will be fully committed to the further development of Oslo Børs VPS, both its stock exchange and the Central Securities Depository (CSD, known as ‘VPS’), through a client-centric plan benefitting all parties of the Norwegian financial ecosystem. Euronext will act accordingly to preserve and develop the specific contribution of Oslo Børs VPS to the Norwegian economy including the Equity Capital Certificates market, the Fish Pool market located in Bergen, the high yield bond market and a seamless efficient listing platform.

CONTACTS -

Pauline Bucaille:                                      +33 1 70 48 24 41   mediateam@euronext.com 

Analysts & investors

Aurélie Cohen:                                       +33 1 70 48 24 17   ir@euronext.com

Euronext Dublin transitions Irish listed companies to Optiq   
 
The migration to Optiq®, Euronext’s proprietary trading platform, enables Euronext Dublin Listed Companies and trading members to benefit from access to Euronext’s Pan-European Order Book.
. 
Amsterdam, Brussels, Dublin, Lisbon, London and Paris – 4 February 2019 – Euronext today announced the successful migration of the 53 companies currently listed on Euronext Dublin to Euronext’s state-of-the-art proprietary trading platform, Optiq®. This transition completes the equity migration from the Irish Stock Exchange plc to Euronext Dublin. 
Companies listed on Euronext Dublin now join the 1,300 listed issuers, together with a combined market capitalisation of over €3.4 trillion, already operating on the next generation trading platform launched in June 2018.  
These listed companies can now avail of the benefits of trading on Optiq, and by joining a single, pan-European order book with thousands of investors, are now on a platform with their EU peers and have access to deeper pools of international capital. As part of being listed on Euronext, Dublin listed companies now have access to the proprietary issuer services of Euronext, including the online Connect portal which gives them access to their trading data, and corporate services such as Investor Relations Manager, My Share Price Live, Skope, and Company Webcast Solutions.  
In addition, as part of the transition which occurred on 4 February 2019, Euronext Dublin has changed the name of its two key markets to align with the rest of the Euronext group. The ‘Main Securities Market’ (MSM), has been renamed ‘Euronext Dublin’, whilst the ‘Enterprise Securities Market’ (ESM) is now ‘Euronext Growth’. There have been no substantive rule changes or functionality changes to these markets. The ‘Global Exchange Market’ (GEM) and ‘Atlantic Securities Market’ (ASM) remain unchanged. 
Daryl Byrne, CEO of Euronext Dublin and Head of Debt & Funds Listing and ETFs, said: “This is a fantastic day for Euronext Dublin. We are excited to extend the benefits of the Euronext model to all of our listed companies and trading members. Irish listed companies can now enjoy access to deeper and broader pools of international capital, enhanced corporate services and visibility as part of this single pan-European orderbook alongside their European peers. We are now in a stronger position to offer more listing solutions to scaling Irish companies looking to access permanent capital through a listing on Euronext which has nearly 1,000 listed SMEs and is the number one listing venue for technology SMEs in continental Europe. We look forward to continuing to work with our listed companies and the Irish ecosystem to unlock the growth and opportunities that participating in a single, pan-European exchange offers.” 
Stéphane Boujnah, CEO and Chairman of the Managing Board of Euronext, said: “As the only pan-European exchange operator and liquidity pool, Euronext now provides listed companies and trading members in Ireland with leadingedge technology, a seamless way to interact and break down barriers to capital and growth, for the benefit of financing the real economy.This is a key milestone in the integration roadmap of Euronext Dublin as they will now be able to leverage the full power of Euronext’s proprietary trading platform, Optiq, and the unique features that come with it. All of this within eleven months after the closing of the acquisition and seven months after the introduction of Optiq to all our issuers. Working hand in hand with the Irish financial and business community, we are very proud of this achievement.”  
 
 
 
 
Note to editor 
Developed in-house by Euronext teams in close collaboration with clients, Optiq® provides cutting-edge performance in terms of latency as well as time to market and flexibility. With modular architecture and the latest generation of components, the platform facilitates the introduction of new products and functionalities for the benefit of Euronext’s clients. 
Optiq® has demonstrated an average performance latency of as low as 15 micro-seconds for order roundtrip as well as for market data, and is highly scalable to accommodate unlimited capacity. Since it went live on 25 June 2018, the platform has handled more than 162 billion messages and 134 million trades. Optiq® comes with improved surveillance and monitoring services which, in addition to its technological performance, equip Euronext’s markets and clients with a highly resilient platform, in particular in times of volatility.

Euronext Dublin hosted a graduation ceremony for #IPOREADY programme participants

Dublin, 22 January 2019- Twelve high-potential companies have graduated from #IPOready, Euronext Dublin’s leadership programme for executives looking to enhance their skillsets for scaling their companies and raising strategic finance. The programme assists executives to get their company funding ready, to understand the sources of funding available and to craft their investment pitch. Chief Executive Officers (CEOs) and Chief Financial Officers (CFOs) from a range of sectors including agri-tech, bio medical technology, construction, engineering, technology and financial services across the island of Ireland took part in the 15-month programme.

#IPOready is supported by Enterprise Ireland and the Ireland Strategic Investment Fund and provides:

• expert training and insights from over 100 top advisors, experienced investors, entrepreneurs, and leading Irish corporates on large scale corporate funding, business development and investor relations;
• networking opportunities with other ambitious companies, experienced leaders and industry experts;
• access to over 25 domestic and international investor organisations to pitch their company’s investment story and receive feedback; and
• support in achieving plans for scaling and strategic finance through one-on-one coaching.

Julie Sinnamon, CEO of Enterprise Ireland said, “Enterprise Ireland’s ambition is to grow the number of Irish businesses of scale, as a back-bone of the economy. Access to appropriate and adequate sources of strategic finance to fund each stage of growth, is essential. We are pleased to collaborate with Euronext on the ‘IPOready programme’ to help demystify the IPO journey and equip business owners with the knowledge and skills to raise funds on the Irish and/or international stock exchanges. We look forward to working with Euronext on future IPOready programmes and to more Irish IPO success stories.”

Padraic Clarke, CFO of Atlantic Therapeutics said, “I would recommend the IPOready programme to any growing Irish company looking to access significant finance as a critical strategic enabler of their growth. Even if an IPO is not the ultimate source of that finance, the learnings that I took away from the programme are relavent to any fundraising situation, and were of benefit to Atlantic Therapeutics in our recent equity fundraising. IPOready has provided us a fantastic opportunity to meet other companies in a similar position and to learn from their experiences as well as providing contacts with potential advisors and investors for the future.”

Laurence Flavin, CFO of Finance Ireland, said “We were delighted to be part of the IPOready programme.  It was a natural step in the progression of a high growth business like Finance Ireland, as Ireland’s largest non-bank lender.  The programme put us in a positive environment with companies of a similar DNA and gave us access to the expertise and resources needed in considering the suitability of an IPO for our business in the future.  We would strongly recommend the programme to other companies with a track record and growth ambitions.”

Orla O’Gorman, Head of Equity Listing, Euronext Dublin said, “Congratulations to the fantastic, ambitious, companies graduating from our #IPOready programme. The strength and caliber of the teams as they developed over the programme never ceased to impress and inspire. We are so excited to watch what these companies will do in the coming months and years ahead and wish them every success on their journey.”

Ambitious growing companies with turnover in excess of €5m and are interested in participating in the #IPOready programme, commencing September 2019, should contact Orla O’Gorman, Head of Equity Listing at OOGorman@euronext.com to register their interest.

Brussels, 17 January 2019 – Euronext Brussels awarded the best performing listed companies and market members during its New Year’s reception. This year’s winners are:

_{Notes to Editors:}

• _{These awards are based exclusively on measurable figures.}
• _{Performance for listed companies means the strongest increase in market capitalization within the indicated peer group over the year 2018.}
• _{The Equity/Bond Finance House awards are based on the number of equity/bond transactions listed on Euronext Brussels, weighted for the amount, advisory role and type of transaction involved.}
• _{The Brokerage House awards are granted to the members who accounted for the highest volumes on the Euronext Brussels securities market in the respective segments.}
• _{The Brussels Brokerage House award is granted to the Belgian member who accounted for the highest volumes on the Euronext Group securities market}
• _{The SME Liquidity Provider award is granted to the member who accounted for the highest liquidity providing volume on companies with market cap < 1 billion €.}
• _{The Derivatives Market award is granted to the member who accounted for the highest number of contracts traded on the Euronext Brussels derivatives market.}

A l’occasion de la 8^ème  Euronext Annual Conference, Euronext a présenté la deuxième édition de son étude sur l’évolution de l’actionnariat direct dans les sociétés de l’indice CAC 40 et de l’indice SBF 120.

L’étude analyse l’actionnariat des sociétés composant les indices CAC 40 et SBF 120 à la fin de chaque année, de fin 2012 à fin 2017 et s’appuie sur les données publiques disponibles et sur des données propriétaires mises à disposition par Factset et Morningstar. L’étude a permis d’identifier environ 60 % de l’actionnariat des sociétés du CAC 40 et du SBF 120 ^(1). Les actionnaires ont été classés en 11 catégories.

1. Données brutes non extrapolées qui ont permis d’identifier environ 60 % de l’actionnariat du CAC 40 et du SBF 120. 40 % de l’actionnariat du CAC 40 et du SBF 120 n’est donc pas connu dans cette étude.

The distribution of the offer document and the making of the offer may in certain jurisdictions be restricted by law, including without limitation in Canada, Australia and Japan. Accordingly, the offer is not made and does not constitute an offer or solicitation in these jurisdictions, or in any jurisdiction or to any person where the making or acceptance of the offer or solicitation would be in violation of the laws or regulations of such jurisdiction.

Euronext announces the launch of its cash tender offer for Oslo Børs VPS

Amsterdam, Brussels, Dublin, Lisbon, London and Paris - 14 January 2019 - Euronext, the leading pan-European exchange, today published the offer document for its previously announced all-cash tender offer to acquire all issued and outstanding shares of Oslo Børs VPS Holding ASA ("Oslo Børs VPS") for NOK 6.24 billion (€625m^[1]). The offer document is available at: Euronext.com

• The offer price is NOK 145 per share, representing a 32 % premium on Oslo Børs VPS's closing price on 17 December 2018^[2] and 34 % on Oslo Børs VPS's 3-month volume-weighted average share price. Each accepting shareholder will also receive an interest payment on the offer price equal to 6 % per annum, from the date of acceptance until fulfilment of the conditions of the offer.

• The acceptance period of the tender offer commences today, will expire at 17:30 Central European Time on 11 February 2019, and can be extended if appropriate. Euronext has already secured support for the offer from Oslo Børs VPS shareholders representing 50.5% of the total number of outstanding shares through irrevocable binding pre-commitments to tender shares in the context of the offer, and share purchases.

• The offer is subject to fulfilment or waiver of certain conditions, including but not limited to minimum acceptance level  of at least 50.01 % of Oslo Børs VPS outstanding shares (including shares already held by Euronext), regulatory approvals, short confirmatory due diligence, a favourable vote from a majority of Euronext shareholders and completion of the transaction before 31 August 2019.

If its offer is accepted, Euronext, already managing the national stock exchanges of five European countries and the Portuguese CSD, will be fully committed to the further development of Oslo Børs VPS, both its stock exchange and the central securities depository (CSD, known as 'VPS'), as well as the  broader Norwegian financial ecosystem. In this context, Euronext's strategic ambition relies on a strong commitment to:

• increase the prominence of Oslo Børs VPS's trading business, by leveraging Euronext capabilities to position it as the key capital markets hub in the Nordic region, capitalising on its leading position in the energy, shipping and seafood sector, and as the launchpad for expansion in the Nordic region;

• offer Oslo Børs VPS's issuers and investors the benefits of access to the largest liquidity pool in Europe;  build a truly pan-European market data offering by combining Oslo Børs VPS's data and audience with that of Euronext;

• make Oslo Børs VPS the Group's center of excellence for all Euronext activities in commodities;

• promote market integrity and inclusion within Euronext's open and decentralised model, including, among other initiatives, the invitation for the Oslo Børs VPS CEO to join the Managing Board of Euronext as country CEO for Norway with Group-wide responsibilities for commodities, and for a leading figure of the Norwegian financial ecosystem to join the Supervisory Board of Euronext, subject to required approvals;

• enhance Oslo Børs VPS's technology and innovation capabilities, notably through the roll-out of Euronext's state-of-the-art proprietary Optiq^® trading technology;

• secure the position of VPS, the national CSD, through commitment to technology investments, operational independence and continued local supervision and regulation;

• invest in educational programmes dedicated to supporting SMEs and family businesses and to develop corporate social responsibility products for the benefit of financing the real economy;

• leverage the depth of Euronext's suite of services for the benefit of Norwegian investors and issuers, by providing access to global FX markets for investors and to a full range of service tools for issuers and investors.

Stéphane Boujnah, Chief Executive Officer and Chairman of the Managing Board of Euronext, said:
"In a rapidly evolving and increasingly competitive global market, Euronext strongly believes that Oslo Børs VPS would improve its competitive positioning, further increase its relevance to the Norwegian financial ecosystem and reinforce its strong existing international listing franchise by joining forces with Euronext, the leading pan-European market infrastructure. If the offer is accepted, Oslo Børs VPS would benefit from the largest European liquidity pool, Euronext's cutting edge technology and innovation capabilities, and access to new asset classes, tools and markets. Oslo Børs VPS would maintain its identity and integrity within Euronext's decentralised model, while the CSD VPS would keep its operational independence to serve the Norwegian investor community, in an integrated framework of governance and supervision. The combination would be a major milestone towards Euronext's vision of building a consistent pan-European marketplace offering best-in-class capital markets services."

For more details on the strategic ambition of Euronext, please refer to paragraph 2.1 and 2.2 of the Offer document, available on www.euronext.com

_{Important Notice}

_{THE OFFER IS BEING MADE TO SHAREHOLDERS OF OSLO BORS VPS RESIDENT IN THE UNITED STATES IN RELIANCE ON THE TIER I EXEMPTION PURSUANT TO RULE 14d-1(c) UNDER THE U.S. SECURITIES EXCHANGE OF 1934, AS AMENDED (THE "EXCHANGE ACT").}

_{THE OFFEROR RESERVES THE RIGHT TO ACQUIRE OR AGREE TO ACQUIRE SHARES OR RIGHTS IN SHARES OUTSIDE THE OFFER DURING THE ACCEPTANCE PERIOD IN ACCORDANCE WITH APPLICABLE LAW AND REGULATIONS AND THE PROVISIONS OF THE EXEMPTION PROVIDED UNDER RULE 14e-5(b)(10) UNDER THE EXCHANGE ACT. ANY OF THE PURCHASES REFERRED TO IN THIS PARAGRAPH MAY OCCUR EITHER IN THE OPEN MARKET AT PREVAILING PRICES OR IN PRIVATE TRANSACTIONS AT NEGOTIATED PRICES. INFORMATION ABOUT SUCH PURCHASES WILL BE DISCLOSED AS AND IF REQUIRED BY APPLICABLE SECURITIES LAWS.}

_{THE OFFER IS BEING MADE FOR THE SECURITIES OF A NORWEGIAN COMPANY AND APPLICABLE DISCLOSURE REQUIREMENTS MAY BE DIFFERENT FROM U.S. DISCLOSURE REQUIREMENTS. IN ADDITION, SHAREHOLDERS RESIDENT IN THE UNITED STATES SHOULD BE AWARE THAT THE OFFER DOCUMENT HAS BEEN PREPARED IN A FORMAT AND STYLE, WHICH DIFFER FROM THE U.S. FORMAT AND STYLE. NEITHER THE U.S. SECURITIES AND EXCHANGE COMMISSION NOR ANY U.S. STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THE OFFER OR PASSED UPON THE ADEQUACY OR COMPLETENESS OF THIS NOTICE OR ANY DOCUMENTATION RELATING TO THE OFFER. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENCE.}

_{FURTHERMORE, THE PAYMENT AND SETTLEMENT PROCEDURE WITH RESPECT TO THE OFFER DIFFERS FROM U.S. PAYMENT AND SETTLEMENT PROCEDURES, PARTICULARLY WITH REGARD TO THE DATE OF PAYMENT OF CONSIDERATION. Completion of the Offer is also subject to the fulfilment and/or waiver of certain conditions, which may result in the Shares of accepting Shareholders being blocked by the Receiving Agent for a period up to the Long-Stop Date (31 August 2019).  Acceptance of the Offer is irrevocable and accepting Shareholders will have no withdrawal rights with respect to their Shares.}

_{THIS ANNOUNCEMENT, AND ANY INVESTMENT ACTIVITY TO WHICH IT RELATES, IS AVAILABLE ONLY TO (I) PERSONS WHO ARE OUTSIDE THE UNITED KINGDOM, (II) INVESTMENT PROFESSIONALS FALLING WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005 (THE “ORDER”), (III) HIGH NET WORTH COMPANIES FALLING WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER, (IV) PERSONS WITHIN THE SCOPE OF ARTICLE 43 OF THE ORDER, OR (V) ANY OTHER PERSONS TO WHOM IT MAY OTHERWISE LAWFULLY BE MADE UNDER THE ORDER (ALL SUCH PERSONS TOGETHER BEING REFERRED TO AS “RELEVANT PERSONS”). THIS ANNOUNCEMENT MAY NOT BE ACTED OR RELIED ON IN THE UNITED KINGDOM BY ANYONE WHO IS NOT A RELEVANT PERSON.}

Une capitalisation boursière de 51,8 millions d’euros

Paris – 9 janvier 2019 – Euronext accueille aujourd’hui la société Baikowski®, leader dans la fabrication de minéraux industriels, pour son premier jour de cotation sur le marché Euronext Growth à Paris.

Fondée en 1904 à Paris, Baikowski® confectionne des poudres et formulations d’alumine ultra pures ainsi que d’autres oxydes tels que le Spinelle, la ZTA, le YAG et le Cérium pour des applications selon différentes techniques. La société centenaire est présente aujourd’hui dans cinq pays et opère dans divers marchés high-techs tels que les marchés de l’éclairage, l’horlogerie, la téléphonie, le microélectronique, l’automobile, la défense et le médical.

L’introduction en Bourse de Baikowski® (code mnémonique : ALBKK) a été réalisée après l’admission par cotation directe le 27 décembre 2018 de 3 671 665 actions au total. L’admission résulte d’un spin-off de la société PSB Industries. Le cours de référence technique a été fixé à 14,10 euros par action. La capitalisation boursière de la société au jour de l’introduction s’élève à environ 51,8 millions d’euros.

A l’occasion de la cérémonie d’introduction en Bourse, Benoît Grenot, Directeur Général de Baikowski®, a déclaré : « Nous allons avec cette entrée sur Euronext, écrire une nouvelle page d’histoire pour notre société centenaire et familiale. Notre ambition est grande, elle est guidée par notre passion d’industriel, notre puissance de R&D, la confiance de nos clients. Je remercie tous nos actionnaires, partenaires et nos équipes pour le travail que nous venons de réaliser et leur enthousiasme sans faille qui doit nous permettre de poursuivre notre développement avec agilité ».

_{À propos de Baikowski®
Société centenaire leader dans la fabrication de minéraux industriels de spécialités, Baikowski® est spécialisée dans la confection de poudres et formulations d’alumine ultra pures, ainsi que d’autres oxydes tels que le Spinelle, la ZTA, le YAG, le Cérium pour des applications céramiques techniques, polissage de précision, cristaux, et additifs ou revêtements. La qualité des produits Baikowski® permet de servir des marchés high-techs variés (éclairage, horlogerie et téléphonie, microélectronique, automobile, défense et médical). En 2017, Baikowski® a réalisé un chiffre d’affaires de 40 millions d’euros. Baikowski® dispose de 3 sites de production implantés en France, aux Etats-Unis et au Japon.
Retrouvez l’ensemble des informations de la société sur www.baikowski.com}

Amsterdam, Brussels, Dublin, Lisbon, London and Paris - 8 January 2019 - Euronext, the leading pan-European exchange in the Eurozone, today announces trading volumes for December 2018.

Cash trading

In December 2018, the average daily transaction value on the Euronext cash order book stood at €7,902.1 million, down -0.9% compared to December 2017 and up +5.7% from the previous month.

The average daily transaction value on the ETF order book^[1] was €255 million, down -6.0% compared to December 2017 and up +11.6% from the previous month. At the end of December 2018, 1,150 ETFs were listed on Euronext compared to 1,048 at the end of December 2017.

For the year 2018, the average daily transaction value on the Euronext cash order book stood at €8,109.5 million (+5.7% compared to the year 2017).

Derivatives trading

In December 2018, the overall average daily volume on derivatives reached 651,367 contracts, up +21.8% compared to December 2017 and up +16.3% compared to the previous month. In detail:

• the average daily volume on equity index derivatives reached 285,459 contracts, up +33.7% compared to December 2017 and up +24.4% from the previous month,
• the average daily volume on individual equity derivatives reached 327,992 contracts, up +15.7% compared to December 2017 and up +18.1% from the previous month,
• the average daily volume on commodity derivatives reached 37,916 contracts, down -0.3% compared to December 2017 and down -28.6% from the previous month.

For the year 2018, the average daily volume on Euronext derivatives stood at 585,310 contracts (+6.4% compared to the year 2017) and open interest was flat at 14,645,289 contracts (-0.5% compared to the end of December 2017).

FX spot trading

In December 2018, the average daily volume on the spot foreign exchange market of FastMatch, operating as a Euronext company since August 2017, stood at $19,112 million, up +22.5% compared to December 2017 and down -5.9% from the previous month.

For the year 2018, the average daily volume on the spot foreign exchange market of FastMatch stood at $20,139 million (+9.3% compared to the year 2017).

Listings

In December 2018, Euronext welcomed four new listings, which together raised €8.6 million. Among them, Lleida.net, the first Spanish company to realise a dual listing on Euronext Growth and Mercado alternativo Bursatil, becoming the third Spanish issuer to join Euronext's markets this year as a result of its
European Tech SME initiative. In addition, €88.9 billion was raised on Euronext in bonds. €11.5 billion was raised in follow-on equity, of which €7.5 billion from EssilorLuxottica and €2.4 billion form Worldline.

Amsterdam, Brussels, Dublin, Lisbon, London and Paris -  28 December 2018 - Euronext, the leading pan-European exchange, announces today that it has raised its commitment from 49.6%, as announced on 24 December 2018^[1], to 50.6% of Oslo Børs VPS Holding ASA ("Oslo Børs VPS") outstanding shares in the context of the tender offer to be launched. This 50.6% commitment is comprised of irrevocable pre-commitments from Oslo Børs VPS shareholders to tender 45.5% of the outstanding shares, and share purchases performed by Euronext, representing a further 5.1% of the capital (2,193,000 shares).

Exceeding the 50% of total outstanding shares threshold shows the interest from Oslo Børs VPS shareholders for Euronext's offer to be launched, satisfying one of the conditions required for its completion and strengthening Euronext's confidence on  its successful outcome. In this end, Euronext will continue to feed into a constructive dialogue with all Oslo Børs VPS stakeholders.

As a reminder¹, as part of the contemplated transaction, Euronext would, as soon as practical, launch a NOK 6.24 billion (€625m^[2]) all-cash offer for the outstanding shares in Oslo Børs VPS, the Norwegian Stock Exchange and national CSD operator, at NOK 145 per share. This represents a 32% premium on Oslo Børs VPS's closing price on 17 December 2018^[3] and 34% on Oslo Børs VPS's 3-month volume-weighted average share price. Euronext's offer will be subject to certain customary conditions including a short due diligence period, minimum acceptance threshold of 50%, regulatory approvals and a favourable vote of Euronext shareholders.

There can be no certainty that a transaction will be completed. The company undertakes no obligation to update the market on the discussions. Euronext will communicate material information, if any, in due course.

Press Release published on 24 December 2018 is available here

Amsterdam, Brussels, Dublin, Lisbon, London and Paris –  24 December 2018 - Euronext, the leading pan-European exchange, has approached the Board of Directors of Oslo Børs VPS Holding ASA (“Oslo Børs VPS”)  to seek its support for a €625m[1] cash tender offer for all the outstanding shares of Oslo Børs VPS, the Norwegian Stock Exchange and national CSD operator, headquartered in Oslo.

If its offer is accepted, Euronext, a pan-European group managing the national stock exchanges of five European countries, would be fully committed to support the development of Oslo Børs VPS and of the broader Norwegian financial ecosystem. Euronext strongly believes that Oslo Børs VPS’ unique strategic and competitive positioning, including a global leading position in seafood derivatives and a deep-rooted expertise in oil services and shipping, would further strengthen Euronext’s position as the leading market infrastructure for the financing of the real economy in Europe. This transaction, if completed, would follow Euronext’s recent acquisition of the Irish Stock Exchange and would represent another key milestone in the delivery of the group’s vision to build a consistent pan-European marketplace offering best-in-class capital markets services.

Following an invitation to consider an acquisition of shares in Oslo Børs VPS organized by a group of its shareholders, Euronext has already secured support for the offer from Oslo Børs VPS shareholders representing 49.6% of all outstanding shares, through a combination of irrevocable pre-commitments to tender their shares in the context of the offer to be launched, and share purchases. As part of the contemplated transaction, Euronext would, as soon as practical, launch a NOK 6.24 billion (€625m[1]) all-cash offer for the outstanding shares in Oslo Børs VPS, at NOK 145 per share, representing a 32% premium on Oslo Børs VPS’s closing price on 17 December 2018[2] and 34% on Oslo Børs VPS’s 3-month volume-weighted average share price. Euronext’s offer will be subject to certain customary conditions including a short due diligence period, minimum acceptance threshold of 50%, regulatory approvals and a favourable vote of Euronext shareholders.

There can be no certainty that a transaction will be completed. The company undertakes no obligation to update the market on the discussions. Euronext will communicate material information, if any, in due course.

3,6 millions d’euros levés et une capitalisation boursière de 25,7 millions d’euros

Paris – 21 décembre 2018 – Euronext Growth accueille aujourd’hui la société PrediLife, acteur innovant de la médecine personnalisée pour prédire les risques de maladies graves.

Fondée en 2004 par Stéphane Ragusa, PrediLife développe des solutions innovantes de médecine prédictive associant techniques médicales éprouvées (tests génétiques, imagerie médicale…) et modèles mathématiques exploitant un grand nombre de données statistiques qui pourraient permettre à chaque individu de définir son profil de risque quant à la survenance de maladies graves. La société commercialise en Europe sa solution Mammorisk® de dépistage dans le cancer du sein. Cette solution répond aux attentes des femmes et des médecins pour la mise en place d’un dépistage personnalisé selon le risque de cancer du sein. 

L’introduction en Bourse de PrediLife (code mnémonique : ALPRE) a été réalisée à la suite de l’admission aux négociations le 21 décembre 2018 de 2 758 154 actions composant le capital social de la société, comprenant 386 154 actions nouvelles émises dans le cadre d’une Offre Globale[1].

Le prix de l’offre a été fixé à 9,30 euros par action. La capitalisation boursière de la société au jour de l’introduction s’élève à 25,7 millions d’euros. Le montant total levé représente 3,6 millions d’euros.

À l’occasion de la cérémonie d’introduction en Bourse, Stéphane Ragusa, Président-directeur général de PrediLife, déclare : « Nous sommes fiers d’annoncer aujourd’hui la réussite de notre introduction en Bourse sur le marché Euronext Growth Paris, marquée par l'arrivée de nouveaux actionnaires que nous tenons à remercier pour la confiance qu’ils nous accordent. Nous souhaitons également remercier nos actionnaires historiques qui ont renouvelé leur soutien. Cette levée de fonds va notamment permettre à PrediLife d’accélérer le déploiement commercial de sa solution MammoRisk® en France et à l’international. »

ACQUISTION OF 78% OF SAAS COMPANY TO COMPLEMENT EURONEXT SERVICES OFFERING WITH RESEARCH AND COMMISSION MANAGEMENT SOLUTIONS FOR BUY-SIDE AND SELL-SIDE

Amsterdam, Brussels, Dublin, Lisbon, London and Paris –  20 December 2018 –  Euronext, the leading pan-European exchange in the Eurozone, today announces the acquisition of 78% of the capital of Commcise, a Software as a Service (“SaaS”) provider of award-winning research evaluation and commission management solutions for financial services firms, from its founders for an initial cash consideration of £27 million.

Founded in 2013 and headquartered in London, Commcise offers a unique cloud-based research commission management, evaluation and accounting solution built to meet the needs of asset managers, brokers and independent research providers.

Commcise is the only vendor which combines research funding, consumption and accounting into a single fully integrated platform. Commcise currently offers  three products:

• CommciseBUY provides asset managers with a cloud-hosted  platform to manage their research funding and associated cost allocation (irrespective of whether its paid through trading, direct charge to clients or P&L), automated trade reconciliation, resource consumption tracking, contract management, research accounting, as well as flexible reporting tools to improve transparency in line with MiFID II regulation;
• CommciseSELL is a cloud-hosted platform for broker-dealers and research providers covering commission management and service pricing;
• CommciseRP is a service pricing and client profitability tool designed to meet the specific needs of independent research providers.

Commcise’s revenue model is based on recurring software licence fees with a high level of contract renewals driven by the quality of its product and its attention to industry needs. At the end of September 2018, Annual Contract Value (ACV) stood at £3.7 million, more than 6 times the ACV generated in 2016.

Already servicing more than 500 customers including some of the world’s largest asset managers, brokers and research providers across Europe, the US and Asia, Commcise’s growth potential is significant both through new targeted clients and cross selling opportunities with existing customers, driven by a strong product pipeline, and the overall market trend for more transparency in research spend. Commcise benefits from regulatory trends led by the enforcement of MiFID II on execution and research unbundling and research valuation, which is driving asset managers to take ownership of their research management process.

The acquisition of Commcise reinforces the deployment of the Agility for Growth strategic plan, announced in May 2016, creating more value for Euronext clients, asset managers and broker-dealers by addressing a strong need generated by MiFID II regulation. This investment fits into the €100-150 million envelope allocated for bolt-on acquisitions and is consistent with Euronext’s disciplined M&A strategy.

The complete founding team of Commcise will remain in place, continuing to grow the business while benefiting from Euronext’s reach and expertise with asset managers and  broker dealers with mid-term liquidity mechanisms.

Stéphane Boujnah, Chief Executive Officer and Chairman of the Managing Board of Euronext, said: “The acquisition of Commcise demonstrates our commitment to increasing our value proposition for all our customers. Capitalising on its track record of delivering new value-added services to issuers, Euronext is addressing the needs of the buy-side and sell-side communities with ways of simplifying their business and efficiently managing research procurement and commissioning across the globe. The acquisition is consistent with our disciplined approach to M&A and our Agility for Growth strategic plan, with the goal of serving Euronext’s client base through a broader range of services. “

Amrish Ganatra, Chief Executive Officer of Commcise, said: ”Euronext’s acquisition of a majority stake in Commcise underlines the leading position we have already achieved in our market.  The senior management team of Commcise is very excited by the next stage of growth and the opportunities we can realise as part of Euronext.  We are fully aligned with Euronext’s strategy of delivering value to customers across the buy-side, sell-side and corporate communities. Euronext already has an impressive eco-system which Commcise will complement to the benefit of the customers of the combined group and a growing set of new business partners.”

CONTACTS 

Media
Pauline Bucaille:      +33 1 70 48 24 41; mediateam@euronext.com 

Analysts & investors
Aurélie Cohen:        +33 1 70 48 24 27; ir@euronext.com

Market capitalisation: €16 million

Paris – 19 December 2018 – Euronext today welcomed Lleida.net, an electronic communications provider, to Euronext Growth. Lleida.net is the first Spanish company with a dual listing on Euronext and on the Spanish market. Today’s listing results from Euronext’s Tech SME initiative launched in September 2017 with the aim of attracting European technology companies to its pan-European markets. Lleida.net is the third listing from a Spanish company this year and the sixth resulting from this initiative.

Lleida.net is dedicated to changing traditional communications processes into services adapted to new technologies. The company has developed the concept of registered electronic communications, making SMS and email messages legally binding documents.

When Lleida.com was first created in 1995, its mission was to offer Internet access to companies, public administrations and private users. Since 2005, it has continued to innovate, becoming a telecoms operator and pioneer in providing SMS services.

Lleida.net (ticker code: ALLLN) was listed on 19 December 2018 through the admission to trading of 16,049,943 shares making up its capital. The listing price was set at €1.02 per share. Market capitalisation on the day of listing was around €16 million.

At the listing ceremony, Sisco Sapena, Lleida.net’s CEO and founder, said: “Listing on Euronext Growth represents the culmination not only of a dream, but of a conscious move into new European markets  that is central to our business model. We strongly believe that, in the near future, many other companies will accompany us on the path we have opened and will join Euronext, the pan-European stock market.”

Euronext is the primary venue for Tech SMEs in Europe with more than 350 issuers representing a total market capitalisation close to €70 billion, and over 850 active institutional investors on the tech segment. 

_{About Lleida.net
Lleida.net was created in 1995 as an Internet access provider. Ten years later in 2005 the company underwent a major transformation and was authorised by Spain’s regulatory authority for telecommunications markets), the Comisión del Mercado de las Telecomunicaciones, to offer its services as a telecoms operator. It then became a pioneer in providing services as an SMS operator. Closely monitoring its clients’ needs, Lleida.net continued to innovate and developed registered electronic communications, making SMS and email messages legally binding documents. It has also created a series of complementary services that add value to its clients’ communications. Lleida.net is strategically positioned to serve clients across the world, from the U.S. to South Africa, India and the Philippines. lleida.net}

Amsterdam – 13 December 2018 – Euronext today announced the results of the quarterly review for the  AEX®, AMX® and AScX® indices. The changes due to the review will be effective from Monday 24 December 2018.

Results of the December 2018 Review

AEX®

No changes in the composition of the index.

AMX®

No changes in the composition of the index.

AScX®

No changes in the composition of the index.

The AEX Steering Committee retains the right to change the published selection, for instance in case of a removal due to a take-over, till the publication of the final data after close of Wednesday 19 December 2018. All events happening after that date will not lead to a replacement of the selected company that possibly needs to be removed from the final selection.

Review AEX family

The AEX family is reviewed quarterly in June, September and December. The full annual review is in March. The quarterly reviews serve to replace removed constituents and to facilitate inclusion of recently listed companies.

Paris – 13 décembre 2018 – Euronext annonce aujourd’hui les résultats de la recomposition des indices de la famille CAC®. Les modifications résultant de cette révision prendront effet le lundi 24 décembre 2018.

Résultats de la révision trimestrielle

Indice CAC 40® :

Pas de changements dans la composition.

Indice CAC® Next 20 :

Pas de changements dans la composition.

Indice CAC® Large 60 :

Pas de changements dans la composition.

Indice CAC® Mid 60 :

En accord avec les règles de la section 5 du livre des règles.

Indice SBF 120® :

En accord avec les règles de la section 5 du livre des règles.

Indice CAC® Small :

En accord avec les règles de la section 5 du livre des règles.

Indice CAC® Mid and Small :

En accord avec les règles de la section 5 du livre des règles.

Indice CAC® All-Tradable :

En accord avec les règles de la section 5 du livre des règles.

Retrouvez la composition et les règles de calcul et de diffusion des indices de la famille CAC sur le site d’Euronext : www.euronext.com/fr/products/indices/FR0003500008-XPAR/market-information

Conformément à nos Règles des Indices (Ajustements du Résultat de la Révision), le Conseil Scientifique des se réserve le droit de modifier la sélection publiée ci-dessus en cas de retrait dû par exemple à un rachat, jusqu’à la publication finale des données à la clôture des marchés le mercredi 19 décembre 2018. Les événements survenant après cette date n’auront pas d’effet sur la sélection des valeurs annoncée lors de la révision. 

Brussels, 12 December 2018 - Euronext today announced the results of the quarterly review for the BEL 20®, BEL Mid®, and BEL Small®. The changes due to the review will be effective from 24 December 2018.

Results of the December 2018 Review:

BEL 20®

No changes

BEL Mid®

BEL Small®

The compiler retains the right to change the published selection, for instance in case of a removal due to a take-over, till the publication of the final data after close of Wednesday 19 December 2018. All events happening after that date will not lead to a replacement of the selected company that possibly needs to be removed from the final selection.

Review BEL 20®, BEL Mid® and BEL Small®

The BEL 20®, BEL Mid® and BEL Small® are reviewed quarterly in June, September and December. The full annual review is in March. The quarterly reviews serve to replace removed constituents and to facilitate inclusion of recently listed companies.